Investor Presentation - First Six Months of 2021
114
Investor presentation First six months of 2021
Insulin market size and volume market share in
North America Operations
Total
Insulin market share and market size (DKK billion)
Long-
acting
37%
42%
102
Fast-
51%
72
acting
58%
Premix
8
28%
Human
15
Novo Nordisk
Competitors
Note: Insulin market numbers do not reflect rebates. See slide 103.
NAO
Market
growth
A Market
share
Insulin volume: market share
60%
10%
198
-7%
-1.2%
8%
50%
39%
6%
-5%
-1.5%
40%
30%
-9%
-0.4%
20%
4%
2%
0%
0%
10%
-17%
-0.5%
0%
May
2018
NN market share
-2% -2%
-4%
May
2021
-6%
-0.9%
Source: IQVIA, May 2021, LHS graph - Value, RHS Graph - Volume, MAT, all countries. Share of growth not depicted due to too high numbers; NN: Novo Nordisk
-Market growth (right axis)
NN growth (right axis)View entire presentation